Stockreport

Press Release: Sanofi completes acquisition of Inhibrx, Inc. [Yahoo! Finance]

Inhibrx Biosciences, Inc.  (INBX) 
PDF Inhibrx, Inc . (“Inhibrx”). The acquisition adds SAR447537 (formerly INBRX-101) to Sanofi's rare disease pipeline, underscoring the company's commitment to pursuing diff [Read more]